Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

LYDOCAN INJECTION 2%

Approval Number

SIN15519P

Drug Name

LYDOCAN INJECTION 2%

Product Name

LYDOCAN INJECTION 2%

Approval Date

August 1, 2018

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

N01BB02

ATC Item Name

lidocaine

Manufacturer Information

Pharmaceutical Manufacturer

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Manufacturers

Y.S.P. Industries (M) Sdn. Bhd.

Active Ingredients

Ingredient Name

Lidocaine Hydrochloride

Strength

200mg/10ml

Drug MonographLidocaine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy